Ayurveda’s Missing Data Crisis: Why Borrowing Biomedical Baselines and Living in Samhita Glory Is Betraying the Acharyas

The Urgent Case for Indigenous, Multicentric, Population-Level Data Generation on Nidāna, Lakṣaṇa, and Prakriti Before We Conduct Another Clinical Trial

By Dr. Aakash Kembhavi, MD (Ayu), MS (Counseling & Psychotherapy)

“Tad eva yuktiṃ brūmaḥ — bahukāraṇa yoga vipākaḥ.” — Charaka Samhita, Sūtrasthāna 11.25 (That alone we call reasoning — the outcome of the combination of multiple causes.)

“Ye tu kecinmahāvaidyā lokaṃ paśyanti cakṣuṣā — te jānanti yathābhūtaṃ, na kevalaṃ śāstracakṣuṣā.” — Charaka Samhita, Vimānasthāna 8.6 (Those great physicians who observe the world with their own eyes — they know things as they truly are, not merely through the eyes of the texts.)

[Disclaimer: This article was developed with AI collaboration as an intellectual tool. All academic positions, research arguments, and professional responsibility for this content rest solely with the author.]

Prologue: The Photograph That Does Not Match the Patient

Imagine a physician who diagnoses every patient not by examining them but by comparing their appearance to a single, aging photograph of what a patient “should” look like. The photograph was taken in a different era, in a different geography, under different environmental conditions, of a different population. Yet every clinical decision — diagnosis, prognosis, treatment selection — is made by reference to this photograph.

This is, with uncomfortable precision, what Ayurvedic clinical research does every day.

The “photograph” is the Samhita description of disease — the Nidāna and Lakṣaṇa documented by the Acharyas in a specific historical context, for a specific population, under specific environmental and dietary conditions, using the observational tools available to them at that time. It is a magnificent photograph — detailed, insightful, extraordinarily sophisticated for its era. But it is a photograph. And photographs do not update themselves.

The patient sitting in front of us today is not the patient in the photograph. They live in urban Karnataka or rural Rajasthan or coastal Odisha. They eat processed food. They sleep in air-conditioned rooms under artificial light. They are sedentary in ways the Acharyas could not have imagined. They are exposed to environmental toxins, electromagnetic fields, psychological stressors, and pharmaceutical residues that did not exist when the Samhitas were composed. They have comorbidities — hypertension co-existing with Amavata, insulin resistance co-existing with Prameha’s modern phenotype, metabolic syndrome presenting as a constellation that maps only partially onto any single Ayurvedic disease category.

And we are diagnosing this patient, grading their symptoms, designing clinical trials, and drawing conclusions about Ayurvedic treatment effectiveness — using data that was never generated, standards that were never established, and reference ranges that were never validated for this population in this era.

The result is not science. It is the performance of science — the wearing of scientific costume over a body that has never been measured.

This article is an argument — urgent, analytical, and at times deliberately uncomfortable — for why the most important research priority in Ayurveda today is not another 30-patient clinical trial. It is the systematic, multicentric, population-level generation of baseline data on Prakriti distribution, Nidāna prevalence, and Lakṣaṇa characterization across the length and breadth of India. Without this foundation, everything we build on top of it is structurally unsound.

Part I: The Magnitude of the Absence — What We Do Not Have and Why It Matters

1.1 We Have No Population-Level Prakriti Data

Prakriti — the constitutional typology that is the cornerstone of Ayurvedic individualized medicine — has no validated population distribution data for contemporary India.

We do not know:

  • What is the prevalence of Vata, Pitta, Kapha, and mixed Prakritis in the Indian population today?
  • Does this distribution vary by geography (coastal versus inland, tropical versus temperate zones)?
  • Does it vary by age, sex, socioeconomic status, urban versus rural residence?
  • Has the distribution changed from what the Acharyas described — and if so, in what direction and by what magnitude?
  • What is the normal range of Prakriti-associated characteristics (pulse qualities, digestive patterns, sleep patterns, skin characteristics) in each Prakriti type in a healthy population?

Without this data, we cannot:

  • Stratify clinical trial participants meaningfully by Prakriti
  • Establish whether a patient’s Prakriti-associated characteristics are normal or deviant
  • Determine whether a treatment has differential effects across Prakriti types
  • Design sampling strategies for epidemiological studies
  • Develop power calculations for Prakriti-stratified trials

The Ayurgenomics research from CSIR-IGIB has provided extraordinary molecular insights into Prakriti correlates — but even this work operates without a validated, nationally representative population distribution of Prakriti types. We are building molecular architecture on a constitutional foundation that has not been mapped.

1.2 We Have No Validated Normative Ranges for Ashtavidha Pariksha

The eightfold examination — Nadi (pulse), Mutra (urine), Mala (stool), Jihvā (tongue), Shabda (voice), Sparsha (skin), Drik (eyes), Ākrti (body build and comportment) — is the Ayurvedic clinician’s primary diagnostic instrument. It is described with extraordinary sophistication in the Samhitas and classical texts.

But we have no normative reference ranges. We have no answer to these questions:

  • What are the normal pulse characteristics (rate, rhythm, volume, wave quality) for a healthy Vata-Prakriti adult male aged 30-40 in North Karnataka, measured by a trained Vaidya?
  • What degree of tongue coating is normal versus indicative of Sama Dosha?
  • What are the inter-rater reliability coefficients for trained Ayurvedic clinicians performing Nadi Pariksha on the same patient?
  • What is the test-retest reliability of Jihvā Pariksha across different lighting conditions, times of day, and post-prandial states?

Without normative ranges, the Ashtavidha Pariksha operates entirely on individual clinical intuition — which may be profound in the hands of an experienced Vaidya but which cannot be standardized, taught systematically, evaluated objectively, or used as a validated outcome measure in clinical research.

Every clinical trial that includes Nadi Pariksha assessment as an outcome measure — and many do — is measuring something for which no normative reference exists. The “improvement” in Nadi characteristics being claimed in these trials is clinician judgment without a validated scale. It is, statistically speaking, unquantified data.

1.3 We Have No Standardized Grading Systems for Ayurvedic Lakṣaṇas

This is the most immediately damaging gap in day-to-day clinical research. Consider the symptom of Sroto-avarodha (channel obstruction) in Prameha. The Samhita describes its characteristics. But:

  • On what scale is it graded? Who designed that scale?
  • Has the scale been validated against any external criterion?
  • Do different examiners using the same scale arrive at the same grade for the same patient?
  • Is the interval between grade 1 and grade 2 equal to the interval between grade 2 and grade 3?
  • What grade represents the threshold of clinical significance — the Minimal Clinically Important Difference (MCID)?

The honest answer to all of these questions, in most cases, is: we do not know, because the scales used in Ayurvedic clinical research were created by individual researchers for individual dissertations — invented, not validated; used once, not replicated; cited subsequently without scrutiny.

Each PG student creates their own grading scale. Each institutional guide approves it based on clinical intuition. Each examiner evaluates it without psychometric training. And the result — a 4-point ordinal scale with no established reliability or validity — becomes the primary outcome measure of a clinical trial on which conclusions about Ayurvedic efficacy are drawn.

This is not data generation. It is the systematic production of unvalidated numbers — quantitative in appearance, meaningless in substance.

Part II: The Biomedical Baseline Problem — Borrowed Frameworks and Their Structural Incompatibility

2.1 How We Currently Design Inclusion Criteria

When an Ayurvedic researcher designs a clinical trial for — let us say — Amavata (which is frequently mapped to Rheumatoid Arthritis), the typical approach is:

  • Use the ACR (American College of Rheumatology) diagnostic criteria for Rheumatoid Arthritis as the primary inclusion criterion, because these are validated, internationally recognized, and will make the study publishable.
  • Add a few Ayurvedic symptoms (Sandhishotha — joint swelling; Sandhi Shoola — joint pain; Angamarda — body ache; Jwara — fever tendency; Agni-daurbalya — digestive weakness; Ama Lakṣaṇas) as secondary inclusion parameters.
  • Assess patients who meet criterion 1 and show some of criterion 2 features.
  • Treat them with an Ayurvedic formulation.
  • Assess outcomes on both biomedical parameters (DAS28, CRP, ESR, RF titres) and Ayurvedic symptom scores.
  • Report improvement on both sets of measures.

What is wrong with this design?

The entire patient selection is driven by a biomedical diagnostic framework that defines a disease entity (Rheumatoid Arthritis) based on immunological, radiological, and clinical criteria developed for a Western population in the twentieth century. Amavata, as described in the Madhava Nidana and elaborated in subsequent texts, is a clinical syndrome defined by Ayurvedic pathogenetic logic — Ama formation, Vata aggravation, Srotas involvement — that does not map one-to-one onto RA.

The overlap between Amavata and RA is partial and complex. Some patients with RA may not have the Ama-dominant pathogenesis central to Amavata. Some patients with Amavata may not meet ACR criteria for RA. By using ACR criteria as the gate, we are selecting a subset of Amavata patients (those who happen to also have RA) and treating them — then concluding that our Ayurvedic formulation is effective for Amavata. The conclusion does not follow from the selection.

More fundamentally: we are using biomedical diagnostic criteria because we have no validated Ayurvedic diagnostic criteria of equivalent rigor. The Nidāna and Lakṣaṇas of Amavata have never been systematically surveyed in a contemporary Indian population to establish:

  • What is the prevalence of each classical Lakṣaṇa in the contemporary Amavata patient?
  • Have new Nidānas (etiological factors) — sedentary lifestyle, dietary patterns unique to the twenty-first century, environmental toxin exposure — been added to the Amavata picture that the classical texts did not describe?
  • What Lakṣaṇas are so reliably present that their absence should exclude the diagnosis?
  • What is the natural disease trajectory of Amavata in the untreated contemporary patient?

Without this data, the Ayurvedic inclusion and outcome criteria in our trials are informed guesses — clinically experienced guesses, perhaps, but guesses nonetheless.

2.2 The Nidāna Gap — Classical Etiology in a Contemporary World

The Samhitas describe Nidānas (etiological factors) for every disease with meticulous detail. For Prameha, the Nidānas include: excessive intake of milk, curd, new grains, sugarcane products, heavy and unctuous foods, sedentary lifestyle, sleeping during the day, mental inactivity. These Nidānas were documented for a population with specific dietary patterns, specific forms of physical labor, and specific environmental exposures.

The contemporary Prameha patient presents with a very different etiological profile:

  • Consumption of ultra-processed foods with refined carbohydrates, industrial seed oils, artificial sweeteners, and food additives
  • Disrupted circadian rhythms from artificial light exposure and shift work
  • Chronic psychological stress (cortisol-driven glycemic dysregulation)
  • Environmental endocrine disruptors (plasticizers, pesticide residues) that interfere with insulin signaling
  • Physical inactivity of a qualitatively different character than the Acharyas described
  • Pharmaceutical exposures (corticosteroids, antipsychotics, beta-blockers) that contribute to metabolic dysfunction

Are these contemporary Nidānas recognized in the classical framework? Are they classified under existing Nidāna categories (Prajñāparādha, Asātmya indriyārtha samyoga, Pariṇāma) — or do they represent genuinely new etiological territory that requires the expansion of our Nidāna taxonomy?

We do not know. Because no systematic study has ever asked this question across a representative Indian population.

The clinical consequence is significant: if we are treating Prameha with classical Nidāna-based management protocols designed for a dietary and lifestyle context that no longer exists — without examining which Nidānas are actually operative in our contemporary patients — we may be addressing etiological factors that are absent while ignoring the ones that are actually driving the disease.

2.3 The Lakṣaṇa Gap — Which Classical Features Are Actually Present Today?

The Samhitas describe the Lakṣaṇas (clinical features) of diseases with extraordinary clinical richness. But when did we last systematically verify that these Lakṣaṇas are present in the contemporary patients presenting to our OPDs?

Consider Udara Roga (abdominal disorders). The classical descriptions include features like Pravāhikā, Ādhmāna, Vibandha, Trishna, Aruchi, Shūla — described in the context of a population without proton pump inhibitors, without functional bowel disease as a recognized entity, without the gut microbiome disruptions consequent to antibiotic overuse, without the visceral hypersensitivity patterns that modern gastroenterology has characterized.

Which of these classical Lakṣaṇas are universally present in our contemporary Udara Roga patients? Which are rare? Which new features — not described in the Samhitas — are consistently present? Which classical features have shifted in their relative prevalence and severity?

We do not know. Because no multicentric, population-level observational study has ever systematically mapped the Lakṣaṇa profile of contemporary Udara Roga patients against classical descriptions.

And because we do not know this, every clinical trial on Ayurvedic management of digestive disorders is using inclusion criteria and outcome measures that are partially validated at best, and clinically irrelevant at worst.

Part III: The Subjectivity Argument — Confronting and Demolishing the Most Common Defense of Our Ignorance

This argument must be addressed directly because it is the most frequently deployed defense of the status quo: “Ayurvedic symptoms are subjective. Objectivity cannot be ascertained. This is the nature of Ayurveda, and we should not try to impose objective measurement on a system built on subjective clinical experience.”

This argument has three versions — a weak version, a moderate version, and a strong version. The weak and moderate versions are partially correct and deserve acknowledgment. The strong version is intellectually untenable and must be rejected.

3.1 The Weak Version: “Some Ayurvedic Symptoms Are Qualitative”

This is true and uncontroversial. Descriptions like Khara sparsha (rough texture), Rūkṣa tvak (dry skin), Nīlatā (bluish discoloration) are qualitative characteristics that cannot be reduced to a single number without loss of clinical meaning. This is not unique to Ayurveda — even in conventional medicine, descriptors like “quality of pain” (burning, stabbing, aching, throbbing) are qualitative.

The appropriate response is not to abandon measurement but to develop ordinal scales with well-defined anchor descriptions — exactly what pain science did with the McGill Pain Questionnaire, and what rheumatology did with the DAS28. These tools operationalize subjective experience into reliable, reproducible categorical measurements without pretending that the underlying experience is purely numerical.

Ayurveda can and must do the same for its Lakṣaṇas. “Vāta-type pain” can be operationally defined as: shifting in location (yes/no), aggravated by cold and relieved by warmth (yes/no), associated with crackling or popping sounds (yes/no), worse at night (yes/no), relieved by movement or rest (specify) — creating a structured characterization that is reproducible, trainable, and statistically analyzable without distorting the clinical reality.

3.2 The Moderate Version: “Some Ayurvedic Assessments Require Expert Clinical Judgment”

This is also true. Nadi Pariksha, in particular, requires years of tactile training and cannot be reduced to a paper questionnaire. The nuances of pulse quality that a skilled Vaidya perceives are real clinical information — but they are currently inaccessible to anyone who has not undergone the same training.

The appropriate response is not to abandon Nadi Pariksha as a data source but to:

  • Establish inter-rater reliability among trained Vaidyas to determine how consistently experts agree
  • Create structured protocols for pulse examination that can be taught systematically
  • Explore technological validation (high-sensitivity pressure transducers, waveform analysis) that can objectively capture some of what expert Vaidyas perceive
  • Use expert consensus methodologies (Delphi method, consensus conferences) to generate validated clinical descriptions that the field can standardize upon

3.3 The Strong Version: “Ayurvedic Symptoms Are Inherently Unmeasurable and Should Not Be Subjected to Quantitative Analysis”

This version must be firmly rejected — for both scientific and philosophical reasons.

Scientifically: The claim that a symptom is “unmeasurable” is a claim about our current tools, not about the symptom itself. Pain was considered unmeasurable until validated pain scales were developed. Depression was considered unmeasurable until validated psychiatric rating scales were developed. Fatigue, quality of life, cognitive function — all of these were once considered too subjective for rigorous measurement, and all of them have yielded to systematic measurement methodology.

The subjectivity of Ayurvedic symptoms is not a barrier to measurement — it is a measurement challenge that requires Ayurveda-specific methodological innovation. The field that gave us the most sophisticated constitutional typology in pre-modern medicine is surely capable of rising to this challenge.

Philosophically: The argument that Ayurvedic symptoms cannot be objectified assumes that the Acharyas had no interest in reproducible, reliable assessment. But the Acharyas described their Lakṣaṇas with the explicit intention that future Vaidyas could use these descriptions to identify the same clinical features in their own patients. A description meant to be applied by others is, by definition, a description that seeks inter-subjective agreement — which is precisely what objective measurement means.

The Acharyas were trying to create a reproducible diagnostic system. The argument that their descriptions cannot be standardized is a claim that the Acharyas failed in their own intention — which is far more disrespectful to their legacy than the effort to validate their observations with modern tools.

The crucial distinction: Objectification does not mean dehumanization. A validated Dosha assessment tool does not eliminate the clinical art of Dosha evaluation — it creates a shared language that allows different clinicians to communicate meaningfully about what they observe, allows researchers to compare observations across centers, and allows patients to have their clinical features described in a manner that is not dependent on the individual idiosyncrasies of a single examiner.

Part IV: The Scientific Program That Ayurveda Needs — A Detailed Blueprint

4.1 Phase 1: The Great Baseline Survey — A National Multicentric Observational Study

The most urgent requirement is a large-scale, multicentric, systematically designed observational study to generate baseline population data on Prakriti distribution, Nidāna prevalence, and Lakṣaṇa characterization across India’s diverse geography, climate zones, and demographic groups.

Study Design: Cross-sectional with longitudinal follow-up component. Multi-stage stratified random sampling to ensure geographic, demographic, and ecological representativeness.

Coverage: Minimum 50,000 participants across at least 25 centers spanning all major geographic zones — North, South, East, West, Northeast, Central; coastal, inland, highland, arid; urban, semi-urban, rural, tribal.

Core Data Elements:

Prakriti Assessment: Using a standardized, validated Prakriti assessment instrument — which must itself be developed and validated as a priority. Multiple existing tools (CCRAS Prakriti questionnaire, institutional variants) should be systematically compared for concordance, and a consensus gold-standard instrument developed through multi-center Delphi methodology. Prakriti assessment should include both self-report and clinician-assessed components, with reliability data reported.

Nidāna Survey: Systematic documentation of dietary patterns, lifestyle habits, occupational exposures, geographical-environmental factors, psychological stressors, and pharmaceutical exposures — mapped against classical Nidāna categories, with provision for documenting Nidānas that do not map to classical categories (creating the database for Nidāna taxonomy expansion).

Lakṣaṇa Characterization: Systematic documentation of clinical features in both healthy and diseased participants, using structured clinical assessment forms with operational definitions for each Lakṣaṇa. This is perhaps the most technically challenging component — and also the most essential, because it is the first step toward generating the normative reference ranges that Ayurvedic clinical research currently lacks.

Ashtavidha Pariksha Assessment: Structured documentation of pulse characteristics, tongue features, urine color and clarity, stool characteristics, voice quality, skin characteristics, and eye features — by trained Ayurvedic clinicians using standardized protocols, with reliability assessment across raters.

Biomedical Correlates: A core panel of biomedical parameters — CBC, metabolic panel, lipid profile, inflammatory markers — to create the bridge data that allows Ayurvedic parameters to be interpreted in relation to biomedical reference ranges, and to identify which classical Lakṣaṇas correlate with measurable biomedical alterations.

Outputs:

  • National and regional Prakriti distribution tables with confidence intervals
  • Normative ranges for Ashtavidha Pariksha findings stratified by Prakriti, age, sex, geography, and season
  • Prevalence tables of classical Nidānas in the contemporary Indian population
  • Catalogue of contemporary Nidānas not described in classical texts with their prevalence
  • Validated grading scales for major Ayurvedic Lakṣaṇas with MCID estimates
  • Population-level data enabling proper sample size calculation for future clinical trials

4.2 Phase 2: Disease-Specific Nidāna-Lakṣaṇa Validation Studies

Once the baseline population data exists, the next phase involves systematic disease-specific studies that ask the fundamental question: Do the Nidānas and Lakṣaṇas described in the Samhitas for each major Vyādhi appear, in their classical form, in the contemporary patients presenting with that condition?

This requires structured case series and case-control studies for each major Ayurvedic disease category — not 30 patients in one institution, but 300-500 patients across 10-15 centers — systematically documenting:

  • Which classical Nidānas are present (prevalence and frequency)
  • Which classical Lakṣaṇas are present (prevalence, frequency, and severity distribution)
  • Which classical Nidānas are absent in contemporary patients (potentially obsolete or population-specific)
  • Which contemporary Nidānas not described classically are present (candidates for Nidāna taxonomy expansion)
  • Which contemporary Lakṣaṇas not described classically are consistently present (candidates for disease definition update)

The outputs of this phase would be disease-specific Contemporary Nidāna-Lakṣaṇa Profiles — validated, population-representative descriptions of each major Ayurvedic disease as it actually presents in twenty-first century India. These profiles would be to Ayurvedic clinical research what the DSM diagnostic criteria are to psychiatric research, or the ACR criteria to rheumatological research — a validated, standardized, reproducible framework for patient identification and outcome assessment.

4.3 Phase 3: Outcome Measure Development and Validation

With normative population data and validated disease-specific Nidāna-Lakṣaṇa profiles in hand, the field can proceed to the systematic development and validation of Ayurveda-specific Patient-Reported Outcome Measures (PROMs) and Clinician-Assessed Outcome Measures for use in clinical trials.

Each measure must go through the full psychometric development process:

  • Item generation (from classical texts, expert consensus, patient interviews)
  • Content validity assessment (does it cover all relevant dimensions?)
  • Face validity (is it comprehensible to patients and clinicians?)
  • Pilot testing and item reduction
  • Reliability testing (internal consistency, test-retest, inter-rater)
  • Construct validity testing (does it correlate as expected with related measures?)
  • Criterion validity testing (does it correspond to meaningful clinical distinctions?)
  • Responsiveness testing (does it detect clinically meaningful change?)
  • MCID determination (what score change represents a clinically meaningful difference?)

Only measures that complete this entire validation process should be used as primary outcomes in clinical trials. This is not an impossible standard — it is the standard that every outcome measure in conventional medicine has had to meet. There is no principled reason why Ayurvedic outcome measures should be exempt from it.

4.4 Phase 4: The Statistical Infrastructure

Once validated measures with known population distributions exist, the full power of appropriate statistical methodology becomes accessible:

Proper sample size calculations can be performed, because we will know the expected effect size, the standard deviation of the primary outcome, and the MCID — all three components of a power calculation.

Appropriate test selection becomes straightforward, because we will know the distributional characteristics of our outcome variables — whether they are normally distributed or skewed, whether they are truly ordinal or approximately interval.

Hypothesis development becomes rigorous, because we will have population-level data on which to base prior probability estimates — enabling Bayesian approaches to clinical inference that are far more powerful and epistemologically honest than frequentist p-value-based hypothesis testing.

Subgroup analyses become meaningful, because Prakriti-stratified analyses can be powered properly — requiring us to recruit sufficient numbers of each Prakriti type to detect differential treatment effects.

Equivalence and non-inferiority margins can be clinically justified, because we will have normative data on what degree of symptom change represents meaningful clinical difference in our population.

The entire statistical edifice of rigorous Ayurvedic clinical research is impossible to construct correctly without this foundational data. With it, it becomes not merely possible but elegant.

Part V: The Acharyas Would Recognize This as Their Own Project

There is a deep irony at the heart of the conservative argument that “we should not disturb or update the Samhita descriptions.” The Acharyas themselves were engaged in exactly the project we are proposing — the systematic, empirical generation of clinical data from observation of real patients in their own time and context.

Charaka did not receive the Charaka Samhita as divine revelation. He received the Agnivesha Tantra — itself a compilation of the teachings of Punarvasu Ātreya, based on observation of patients — and revised it based on his own clinical experience and that of his contemporaries. Dridhabala further revised it centuries later, explicitly acknowledging that sections had been lost and needed reconstruction. The Samhita tradition is a tradition of successive evidence-based revision, not of fixed, permanent truth.

Charaka explicitly instructs the Vaidya: “Na keval shastra cakṣusha paśyet” — do not rely on the eye of the text alone. He demands that clinical observation supplement textual knowledge. The physician who sees only what the text tells them to see, without genuinely observing the patient before them, is failing the Acharya’s mandate.

Vagbhata’s integration of Charaka and Sushruta with the medical knowledge of his own era — incorporating new drugs, new formulations, new clinical insights — is a model of exactly the kind of living, updating, evidence-responsive knowledge system that we are advocating.

What we are proposing is not a departure from the Samhita tradition. It is its authentic continuation. The Acharyas documented the Nidānas and Lakṣaṇas of their patients in their era. We must document the Nidānas and Lakṣaṇas of our patients in our era. To fail to do this — to treat the Samhita descriptions as permanently and universally valid without empirical verification — is to misunderstand the epistemological spirit of the tradition.

The Samhitas were not meant to be the end of Ayurvedic knowledge generation. They were meant to be the beginning.

Part VI: The Uncomfortable Consequences of Not Having This Data

Let us be direct about what the absence of this data is actually costing us.

6.1 We Cannot Diagnose Reliably Across Institutions

Without standardized, validated Nidāna-Lakṣaṇa criteria, the diagnosis of “Amavata” by a Vaidya in Jamnagar and by a Vaidya in Chennai may refer to clinically different patient profiles. A patient who would be diagnosed as Amavata at one institution may be diagnosed as Sandhivata at another. This diagnostic heterogeneity means that “clinical trials of Amavata management” across different institutions are, potentially, trials on different patient populations — making multi-center pooling of data scientifically invalid and meta-analyses across trials meaningless.

6.2 We Cannot Determine Whether Our Treatments Are Working for the Right Reasons

If a patient is selected for an Amavata trial using ACR criteria for RA, treated with an Ayurvedic formulation designed for the Ama-dominant pathogenesis of Amavata, and improves — we cannot know whether the improvement is because: a) The patient had Amavata and the treatment addressed its Ama-dominant pathogenesis correctly b) The patient had RA without significant Ama involvement and the treatment’s anti-inflammatory properties produced biomedical improvement through a mechanism unrelated to the Ayurvedic therapeutic rationale c) The patient had a spontaneously remitting episode coinciding with the trial

Without validated Ayurvedic diagnostic and outcome criteria, we cannot distinguish between these possibilities — which means we cannot understand why our treatments work when they do, and therefore cannot optimize them intelligently.

6.3 We Are Teaching Our Students to Work Without a Reference System

A student of conventional medicine who wants to know the normal range of serum creatinine, the diagnostic criteria for systemic lupus, or the validated outcome measures for clinical depression has access to decades of validated, population-representative reference data. The knowledge structure exists. The student’s role is to learn it and apply it.

A student of Ayurveda who wants to know the normative range of Nadi characteristics in a healthy Vata-Prakriti adult, the validated diagnostic criteria for Amavata, or the standardized outcome scale for Sandhivata — finds nothing. Or, more accurately, finds a multiplicity of inconsistent, unvalidated institutional variants that cannot be reconciled with each other.

We are training our students to practice in a measurement vacuum — asking them to make clinical and research judgments without the reference infrastructure that makes those judgments meaningful. This is not a pedagogical limitation. It is a structural injustice to every student who enters our programs in good faith, expecting to be equipped with the tools of their profession.

6.4 We Are Vulnerable to Regulatory Dismissal — Correctly

When regulatory bodies, funding agencies, or scientific journals evaluate Ayurvedic clinical research and find disease definitions that vary by institution, outcome measures that were invented for individual dissertations, and statistical analyses that apply parametric tests to ordinal data without normality verification — they are not being unfair to Ayurveda. They are applying the standards of scientific evidence that every medical system must meet.

The response to this dismissal cannot be to argue that Ayurveda should be evaluated differently. The appropriate response is to build the foundational data infrastructure that makes rigorous evaluation possible — and then present work that meets the standard. We cannot simultaneously claim scientific status for Ayurveda and resist the methodological requirements of science.

Part VII: The Political Economy of Inaction — Why This Has Not Been Done

The question that this entire article implicitly raises is: if the need is so urgent and the consequences of inaction so severe, why has this foundational data not been generated in the seventy-plus years since Indian independence?

The answers are uncomfortable but necessary.

Funding priorities have historically favored clinical trials — the kind of research that produces publishable results in reasonable timeframes — over the unglamorous, time-consuming, methodologically complex work of baseline data generation. Multicentric observational studies require years of coordination, large budgets, and produce outputs (normative reference tables, validated scales) that are less citable than positive clinical trial results.

Institutional fragmentation means that no single institution has the capacity, reach, or authority to conduct the kind of nationally representative multicentric study that is needed. CCRAS (Central Council for Research in Ayurvedic Sciences) has the mandate but has historically lacked the methodological infrastructure and multi-institutional coordination to execute at this scale.

Academic incentive structures reward individual researchers who publish clinical trials over those who contribute to foundational data infrastructure. A professor who conducts a 30-patient clinical trial and publishes it in a journal receives the same academic credit as one who contributes to a 50,000-patient baseline survey — but the former requires three years and the latter requires ten. The incentive structure drives researchers toward the former, regardless of which is more scientifically important.

Methodological illiteracy — documented in detail in our companion article on statistical literacy — means that a significant proportion of the field does not understand why this baseline data is necessary. If you do not understand the statistical requirements of proper sample size calculation, you do not understand why the absence of normative Lakṣaṇa data makes it impossible to calculate sample sizes properly. Ignorance of the problem perpetuates the ignorance.

The comfort of living in past glory — which must be named honestly — is perhaps the most psychologically powerful barrier. The Samhitas are magnificent. The clinical insights of the Acharyas are genuinely extraordinary. The temptation to rest in that magnificence — to say, “we have this great tradition, and that is enough” — is understandable. It is also a profound abdication of scientific responsibility.

The Acharyas did not rest in the glory of their predecessors. They built. They observed. They revised. They challenged. They demanded evidence. The least we owe them is to do the same.

Part VIII: A Call to Action — What Must Happen Now

The scale of what is needed requires institutional courage and coordination of a kind that Ayurvedic academia has not yet demonstrated. But it is not impossible. And it is not optional — not if we are serious about Ayurveda as a living, evidence-generating medical system rather than a cultural heritage to be preserved in institutional amber.

Immediate priorities:

Establish a National Ayurveda Data Consortium (NADC) — a formally constituted multi-institutional collaboration, coordinated by CCRAS with participation from all national institutes and a representative selection of state and private Ayurvedic colleges. Its mandate: to design, fund, and execute the baseline multicentric observational study described in Part IV.

Develop and validate a National Prakriti Assessment Instrument — using Delphi methodology, systematic literature review, and multi-center reliability testing. One instrument. Validated. Standardized. Used everywhere.

Mandate systematic OPD data collection across all NCISM-affiliated institutions, using standardized electronic forms that capture Nidāna and Lakṣaṇa data in structured format. Even without a formal study, mandatory structured OPD documentation across 350+ Ayurvedic medical colleges would generate an extraordinarily rich dataset within five years.

Redesign PG dissertations to include, as a mandatory component, structured baseline clinical characterization of the study population using validated Ayurvedic assessment instruments — contributing to the national database with every dissertation completed.

Fund outcome measure development as a research priority equal to or above clinical trials. Without validated measures, clinical trials cannot be interpreted. The logical sequence is: validate measures first, then conduct trials.

Establish a National Ayurvedic Clinical Data Repository — a federated database where structured clinical data from participating institutions can be aggregated, de-identified, and made available for secondary analysis.

Conclusion: The Debt We Owe — To the Acharyas, to Our Students, and to Our Patients

The Acharyas observed. They documented. They generated data — the best data they could generate with the tools available to them in their era, for the patients available to them in their geography, in their time. They did not pretend to have data they lacked. They did not borrow data from other traditions and call it their own. They built, laboriously and systematically, from direct observation of the world as they found it.

We are working with instruments of observation incomparably more powerful than anything the Acharyas had access to. We have structured questionnaires, biostatistical software, electronic data collection systems, genomic analysis, and neuroimaging. We have methodological frameworks developed over a century of global clinical research. We have the capacity to generate the kind of population-level, validated, statistically analyzable data that would have been inconceivable to the Acharyas — and that would have made them weep with intellectual longing.

And we are not using these instruments. We are conducting 30-patient trials with unvalidated outcome measures, borrowed diagnostic criteria, uninvestigated normality assumptions, and no primary outcomes. We are calling this Ayurvedic research.

The Acharyas, looking at this, would not be proud of our fidelity to their tradition. They would be bewildered by our abandonment of their method.

The method was: observe the world as it is. Document what you find. Reason from evidence. Build knowledge systematically. Update when the evidence demands it.

We have the tools to do this at a scale and rigor the Acharyas never imagined possible. The only thing we lack is the institutional will, the methodological clarity, and the honest acknowledgment that we are not yet doing science — we are doing the performance of science.

That performance is not good enough. Our patients deserve the real thing. Our students deserve the real thing. The Acharyas deserve the real thing.

It is time to stop living in the light of a tradition we have stopped contributing to — and start generating the data that will allow Ayurveda to illuminate the twenty-first century on its own terms, with its own evidence, and with the scientific rigor that was always the Acharyas’ deepest intention.

Ye tu kecinmahāvaidyā lokaṃ paśyanti cakṣuṣā — te jānanti yathābhūtaṃ, na kevalaṃ śāstracakṣuṣā.

Those great physicians who observe the world with their own eyes — they know things as they truly are, not merely through the eyes of the texts.

It is time to open our eyes.

Share your thoughts in the comments below.